Skip to main content

Bioinformatics Publishing Launches Global News Service, Newsletter

Premium

NEW YORK--Welcome to BioInform! Bioinformatics Publishing LLC is pleased to present the premier issue of a new biweekly newsletter dedicated to the practice and the business of bioinformatics. Widely identified as one of the leading disciplines of the 21st century, bioinformatics has long deserved a news service for which it is the exclusive focus. Now, BioInform will fill this critical information gap.

Each issue of BioInform will bring an exciting, lively, and informative combination of up-to-the-minute inside news; profiles of the people, companies, laboratories, and technologies that define this cutting-edge field; new products and services; and a schedule of upcoming events. In addition, the BioInform web site (http://www.bioinform.com) will soon be upgraded.

Every two weeks, the editors of BioInform will scour the globe for the most compelling stories in bioinformatics in order to bring you the news you need to optimize productivity and help your organization fulfill its mission. But the information business is a two-way street. We'd also like to hear from you about how we can make BioInform even more useful in the coming months. Drop a line to [email protected] to share your thoughts.

Filed under

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.